DrCharles Agbuduwe

Dr Charles Agbuduwe is an academic haematologist with translational and clinical research activity in the development of novel cell-based immune therapies. His current research fellowship at Imperial, based at the Karadimitris Lab, focuses on the expansion and engineering of unconventional T cells for adoptive cell therapy against myeloma. His previous research appointments include the NIHR Academic Clinical Fellowship in Cambridge and recently, a CRUK Clinical Research Training Fellowship at UCL which focused on optimising Chimeric Antigen Receptor (CAR) therapy against solid tumours. He has also led a number of clinical research projects leading to publications and conference presentations.

Dr Agbuduwe maintains clinical activity as an honorary haematology consultant at Imperial College Healthcare NHS Trust including weekly myeloma clinics at Hammersmith Hospital.